ROCKVILLE, Md. & ALAMEDA, Calif.--(BUSINESS WIRE)--Celera Group (NYSE:CRA), an Applera Corporation business, and Berkeley HeartLab, Inc. (BHL), a privately held company, today announced they have signed a definitive agreement whereby Celera will acquire BHL for approximately $195 million in cash, subject to reduction for certain BHL transaction costs. BHL is a cardiovascular healthcare company with a broad portfolio of CLIA certified tests and disease management services focused on the secondary prevention market. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close during the second quarter of Celera’s fiscal 2008.
